149 related articles for article (PubMed ID: 27498867)
1. The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor Metabolism.
Izreig S; Samborska B; Johnson RM; Sergushichev A; Ma EH; Lussier C; Loginicheva E; Donayo AO; Poffenberger MC; Sagan SM; Vincent EE; Artyomov MN; Duchaine TF; Jones RG
Cell Rep; 2016 Aug; 16(7):1915-28. PubMed ID: 27498867
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.
Valencia T; Kim JY; Abu-Baker S; Moscat-Pardos J; Ahn CS; Reina-Campos M; Duran A; Castilla EA; Metallo CM; Diaz-Meco MT; Moscat J
Cancer Cell; 2014 Jul; 26(1):121-135. PubMed ID: 25002027
[TBL] [Abstract][Full Text] [Related]
3. miR-17∼92 in lymphocyte development and lymphomagenesis.
Labi V; Schoeler K; Melamed D
Cancer Lett; 2019 Apr; 446():73-80. PubMed ID: 30660648
[TBL] [Abstract][Full Text] [Related]
4. Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α.
Faubert B; Vincent EE; Griss T; Samborska B; Izreig S; Svensson RU; Mamer OA; Avizonis D; Shackelford DB; Shaw RJ; Jones RG
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2554-9. PubMed ID: 24550282
[TBL] [Abstract][Full Text] [Related]
5. The miR-17~92 cluster activates mTORC1 in mantle cell lymphoma by targeting multiple regulators in the STK11/AMPK/TSC/mTOR pathway.
Jiang C; Bi C; Jiang X; Tian T; Huang X; Wang C; Fernandez MR; Iqbal J; Chan WC; McKeithan TW; Lewis RE; Fu K
Br J Haematol; 2019 May; 185(3):616-620. PubMed ID: 30198569
[No Abstract] [Full Text] [Related]
6. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.
Masui K; Tanaka K; Akhavan D; Babic I; Gini B; Matsutani T; Iwanami A; Liu F; Villa GR; Gu Y; Campos C; Zhu S; Yang H; Yong WH; Cloughesy TF; Mellinghoff IK; Cavenee WK; Shaw RJ; Mischel PS
Cell Metab; 2013 Nov; 18(5):726-39. PubMed ID: 24140020
[TBL] [Abstract][Full Text] [Related]
7. Tuberous sclerosis complex is required for tumor maintenance in MYC-driven Burkitt's lymphoma.
Hartleben G; Müller C; Krämer A; Schimmel H; Zidek LM; Dornblut C; Winkler R; Eichwald S; Kortman G; Kosan C; Kluiver J; Petersen I; van den Berg A; Wang ZQ; Calkhoven CF
EMBO J; 2018 Nov; 37(21):. PubMed ID: 30237309
[TBL] [Abstract][Full Text] [Related]
8. miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance.
Deng X; Liu Z; Liu X; Fu Q; Deng T; Lu J; Liu Y; Liang Z; Jiang Q; Cheng C; Fang W
Mol Ther; 2018 Apr; 26(4):1066-1081. PubMed ID: 29525743
[TBL] [Abstract][Full Text] [Related]
9. Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.
Burger ML; Xue L; Sun Y; Kang C; Winoto A
Blood; 2014 Jun; 123(26):4089-100. PubMed ID: 24735967
[TBL] [Abstract][Full Text] [Related]
10. Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis.
Ding L; Zhang Y; Han L; Fu L; Mei X; Wang J; Itkow J; Elabid AEI; Pang L; Yu D
Oncogene; 2018 Mar; 37(10):1293-1307. PubMed ID: 29284789
[TBL] [Abstract][Full Text] [Related]
11. mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
Kalim KW; Zhang S; Chen X; Li Y; Yang JQ; Zheng Y; Guo F
PLoS One; 2017; 12(8):e0183266. PubMed ID: 28813526
[TBL] [Abstract][Full Text] [Related]
12. MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer.
He Z; Li Z; Zhang X; Yin K; Wang W; Xu Z; Li B; Zhang L; Xu J; Sun G; Wang L; Li Q; Huang X; Zhang L; Zhang D; Xu H; Xu Z
Cell Death Dis; 2018 May; 9(5):505. PubMed ID: 29725130
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin Suppresses Tumor Growth and Alters the Metabolic Phenotype in T-Cell Lymphoma.
Kittipongdaja W; Wu X; Garner J; Liu X; Komas SM; Hwang ST; Schieke SM
J Invest Dermatol; 2015 Sep; 135(9):2301-2308. PubMed ID: 25897830
[TBL] [Abstract][Full Text] [Related]
14. Harnessing impaired energy metabolism in cancer cell: small molecule- mediated ways to regulate tumorigenesis.
Govardhan KS; Ramyasri K; Kethora D; Ravishekar Y; Prasenjit M
Anticancer Agents Med Chem; 2011 Mar; 11(3):272-9. PubMed ID: 21434854
[TBL] [Abstract][Full Text] [Related]
15. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
16. microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression.
Gu DN; Jiang MJ; Mei Z; Dai JJ; Dai CY; Fang C; Huang Q; Tian L
Cancer Lett; 2017 Aug; 400():69-78. PubMed ID: 28450156
[TBL] [Abstract][Full Text] [Related]
17. Suppression of Glut1 and Glucose Metabolism by Decreased Akt/mTORC1 Signaling Drives T Cell Impairment in B Cell Leukemia.
Siska PJ; van der Windt GJ; Kishton RJ; Cohen S; Eisner W; MacIver NJ; Kater AP; Weinberg JB; Rathmell JC
J Immunol; 2016 Sep; 197(6):2532-40. PubMed ID: 27511728
[TBL] [Abstract][Full Text] [Related]
18. Target of Rapamycin Complex 2 regulates cell growth via Myc in Drosophila.
Kuo Y; Huang H; Cai T; Wang T
Sci Rep; 2015 May; 5():10339. PubMed ID: 25999153
[TBL] [Abstract][Full Text] [Related]
19. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis.
Liu P; Ge M; Hu J; Li X; Che L; Sun K; Cheng L; Huang Y; Pilo MG; Cigliano A; Pes GM; Pascale RM; Brozzetti S; Vidili G; Porcu A; Cossu A; Palmieri G; Sini MC; Ribback S; Dombrowski F; Tao J; Calvisi DF; Chen L; Chen X
Hepatology; 2017 Jul; 66(1):167-181. PubMed ID: 28370287
[TBL] [Abstract][Full Text] [Related]
20. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]